24,828 results on '"Risperidone"'
Search Results
2. Efficacy of Treatment With Pramipexole or Risperidone in Patients With Refractory Obsessive-compulsive Disorder (OCD) (OCD-RT)
3. Magnetic Seizure Therapy for Psychotic Disorders
4. CLOZAPINE Response in Biotype-1
5. Risperidone 1 mg Tablet in Healthy Subjects Under Fasting Conditions
6. Risperidone 1 mg Tablets Dosed in Healthy Subjects Under Fed Conditions
7. An Active-Controlled Early Phase Study of MK-8189 in Adults With Schizophrenia (MK-8189-005)
8. 'Extended' (Alternate Day) Antipsychotic Dosing
9. Imaging the Effects of Serotonin 2A Receptor Modulation on Synaptic Density in Treatment-resistant Depression (SYNVEST) (SYNVEST)
10. Does Psilocybin Require Psychedelic Effects to Treat Depression? (PSI-RIS)
11. Efficacy and Safety of MK-8189 in Participants With an Acute Episode of Schizophrenia (MK-8189-008)
12. Long-term Antipsychotic Pediatric Safety Trial (LAPS)
13. Pharmacokinetics, Safety and Tolerability of Different Formulations and Dose Strengths of Quarterly Risperidone (QUAR) in Patients With Schizophrenia (QUARTZ)
14. Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS) (POPS or POP02)
15. Lumateperone for the Improvement of Apathy in Patients With Psychotic Symptoms.
16. A Clinical Study That Will Assess How Food Moves Through the Stomach and Effects Blood Glucose Levels in Subjects With Schizophrenia Taking SEP-363856 or and Prior Antipsychotic (PA) Standard
17. A Clinical Study That Will Assess the Effect of SEP-363856 or Prior Antipsychotic (PA) Standard of Care on Body-weight Associated Parameters in Subjects With Schizophrenia
18. Relationship Between Efficacy of Lumateperone and Brain Glutamate and Dopamine (Lumafep)
19. A Study to Assess the Treatment of Schizophrenia With Paliperidone Palmitate in Rwandan Healthcare Settings (CASPAR)
20. Result of tDCS in ASD Children With Comorbidities Like PANDAS, Rare Genetic Diseases or Autoimmune Disorders (tDCS&ASD)
21. The Psychiatric and Cognitive Phenotypes in Velocardiofacial Syndrome (VCFS)
22. Biomarkers of Conversion Risk and Treatment Response in Early-Stage Schizophrenia
23. Pragmatic Trial Comparing Weight Gain in Children With Autism Taking Risperidone Versus Aripiprazole
24. Atypical Antipsychotic-induced Mitochondrial Dysfunction in Patients With Schizophrenia
25. Study to Compare Clozapine vs Treatment as Usual in People With Intellectual Disability & Treatment-resistant Psychosis (CLOZ-AID)
26. Study to Evaluate the Pharmacokinetics (PK) and Safety/Tolerability of Long-Acting Oral LYN-005
27. Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies
28. A Study to Evaluate the Ability of Conducting a Study of Oral Risperidone Followed by Paliperidone Palmitate in Rwandan Healthcare Facilities
29. Striatal Connectivity and Clinical Outcome in Psychosis
30. Risperidone for the Treatment of Huntington's Disease Involuntary Movements
31. Pharmacokinetics and Safety of a Novel Extended‐Release Microsphere Formulation of Risperidone in Patients with Schizophrenia or Schizoaffective Disorder.
32. Catatonia in Intellectual Disability: A Case Discussion Exploring Confounding Factors and Challenges in Diagnosis.
33. Evaluation of the Impact of the Addition of Atypical Antipsychotics to Continuous Infusion Propofol Therapy.
34. Impact of CYP2D6*2, CYP2D6*35, rs5758550, and related haplotypes on risperidone clearance in vivo.
35. Sex difference alters the behavioral and cognitive performance in a rat model of schizophrenia induced by sub-chronic ketamine.
36. Comparative effect of atorvastatin and risperidone on modulation of TLR4/NF-κB/NOX-2 in a rat model of valproic acid-induced autism.
37. An economic model to understand the cost-effectiveness of olanzapine orally dispersible tablets (ODT) and olanzapine film coated tablets as a group compared with other oral atypical antipsychotics for treating schizophrenia in Morocco.
38. Metabolic Side Effects of Risperidone in Pediatric Patients with Neurological Disorders: A Prospective Cohort Study.
39. Transcriptome analysis to explore the mechanism of downregulated TNIK influencing the effect of risperidone.
40. Inhibition of reactive oxygen species production accompanying alternatively activated microglia by risperidone in a mouse ketamine model of schizophrenia.
41. Virtual screening and experimental analysis of caspase-7 inhibitors as candidates for extending the lifespan of CHO cells.
42. Association of new-onset diabetes mellitus in adults with schizophrenia treated with clozapine versus patients treated with olanzapine, risperidone, or quetiapine: A systematic review and meta-analysis.
43. Advancements in Non-Dopaminergic Treatments for Schizophrenia: A Systematic Review of Pipeline Developments.
44. Development of a population pharmacokinetic model for the novel long‐acting injectable antipsychotic risperidone ISM®.
45. Drug-Induced Gynecomastia: Data Mining and Analysis of the FDA Adverse Event Reporting System Database.
46. TREATMENT OF METHADONE PATIENTS WITH NEUROLEPTIC THERAPY AND HYPERPORLACTINEMIA.
47. The use of psychotropic medications in autistic individuals (21 years and younger) in Western Australia: A preliminary investigation.
48. A Long-Term Safety and Tolerability Study of TV-46000 for Subcutaneous Use in Patients with Schizophrenia: A Phase 3, Randomized, Double-Blinded Clinical Trial.
49. Comparison of antipsychotic drug use in children and adolescents in the Netherlands before and during the COVID-19 pandemic.
50. Risperidone Pellets, Pycnogenol ® , and Glucomannan Gummy Formulation for Managing Weight Gain and ADHD in Autistic Children.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.